This invention relates to a solid pharmaceutical composition comprising metformin. The composition of the invention comprises a solid dosage form which provides sustained release of the metformin. The invention also includes a process of preparing such compositions and method of treating type-2 diabetes mellitus by ...

The present invention relates to a novel stable chewable composition comprising microencapsulated Ferric Saccharate along with one or more pharmaceutically acceptable excipients wherein the said chewable compositions are devoid of metallic taste of iron. The present invention also discloses the process of preparatio...

ABSTRACT This invention relates to a tablet dosage form comprising (i) 70-95% of one or more active ingredient(s) and (ii) 5-30% of rate controlling matrix forming polymer and pharmaceutically acceptable excipients(s); wherein the amount of active ingredient(s) in a unit dosage form is 500mg to 1200mg; the total we...

This invention relates to a coated tablet comprising a fixed dose combination of Metformin, Voglibose and Glimepiride or pharmaceutically acceptable salt there. The composition of present invention comprises a core containing Metformin dispersed in a rate controlling polymer matrix along with one or more excipients....